Known or previously unrecognized candida fungal infection may present more prominent symptoms during therapy with tinidazole and requires treatment with an appropriate antifungal agent.
For patients failing both the single dose and 7 day metronidazole regimens, tinidazole 2 g PO for 7 days should be considered.
Tinidazole was reported to be mutagenic in certain cell culture tests but was not carcinogenic in animal tests.
Do not eat or drink milk, cheese, or dairy products that may not have been pasteurized. Because the pharmacokinetics of tinidazole in patients with severe renal impairment CrCL.
To combat secondary bacterial infections, antibiotics such as tetracycline are used in combination with either metron tinidazole. As with metronidazole, tinidazole may enhance the effect of warfarin and other coumarin anticoagulants, resulting in a prolongation of prothrombin time.
A blood test is also available. What other information should I know.
Ask your doctor before use if you are taking the following medications:
In two of the acute studies, patients with ADHD and comorbid alcoholism or social anxiety disorder were studied and in both studies ADHD symptoms were improved.
While patients may notice improvement with Lexapro therapy in 1 to 4 weeks, they should be advised to continue therapy as directed.
When treating a pregnant woman, the physician should carefully consider both the potential risks of taking an MAOI, particularly the risk of hypertensive crisis during pregnancy, along with the established benefits of treating depression with an antidepressant.
This rare but very serious disease can cause death and must be treated in a hospital.
Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram.
It is important to follow the instructions given by your doctor. Metallic taste, nausea, headache, vomiting, dark urine, flushing, anorexia, diarrhoea, tiredness, transient leucopenia. OCs is less clear, but alternative or additional contraception may be advisable in selected circumstances.
Coadministration may result in elevated tinidazole plasma concentrations. The use of tinidazole in pregnant patients has not been studied for bacterial vaginosis.
Tinidazole is a CYP3A4 substrate and crizotinib is a moderate CYP3A4 inhibitor.